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Abstract
As the incidence of obesity is reaching ‘epidemic’ proportions, there is currently widespread interest in the impact of dietary components
on body-weight and food intake regulation. The majority of data available from both epidemiological and intervention studies provide
evidence of a negative but modest association between milk and dairy product consumption and BMI and other measures of adiposity,
with indications that higher intakes result in increased weight loss and lean tissue maintenance during energy restriction. The purported
physiological and molecular mechanisms underlying the impact of dairy constituents on adiposity are incompletely understood but may
include effects on lipolysis, lipogeneis and fatty acid absorption. Furthermore, accumulating evidence indicates an impact of dairy constitu-
ents, in particular whey protein derivatives, on appetite regulation and food intake. The present review summarises available data and
provides an insight into the likely contribution of dairy foods to strategies aimed at appetite regulation, weight loss or the prevention
of weight gain.
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Introduction
In addition to being a high-quality protein source, milk and
dairy products represent important sources of Ca, iodine,
riboflavin and B12, providing 60, 55, 52 and 150 % of the
adult reference nutrient intakes in the UK for these nutri-
ents, respectively(1). In recent years, attention has focused
on the macronutrient composition of dairy products and
the potential effects of dairy consumption on the risk of
chronic diseases such as CVD, and more recently, obesity
and its associated metabolic disorders such as the meta-
bolic syndrome and type 2 diabetes. The present review
specifically examines the evidence from epidemiological
studies and intervention trials that have investigated the
relationship between dairy product consumption and diet-
ary Ca, and measures of adiposity. Furthermore, potential
mechanisms underlying the possible relationship between
dairy constituents and body-weight regulation, and in
particular appetite, are explored. The review commences
by detailing current and predicted trends in obesity inci-
dence, and worldwide consumption patterns of milk and
other dairy products.
Obesity prevalence and projections
The prevalence of excess body weight has reached epi-
demic proportions, with more than 1·6 billion adults being
overweight (BMI $ 25 kg/m2) worldwide of which 400
million are clinically obese (BMI $ 30 kg/m2)(2). Table 1
illustrates the current and predicted future prevalence of
overweight and obesity in various parts of the world. The
UK obesity rates are the third highest in Europe, with the
prevalence of overweight individuals (including obese)
being 61·9 % for females and 65·7 % for males and 24·2 %
and 21·6 % classified as obese, respectively(3).
*Corresponding author: Dr Anne M. Minihane, email a.minihane@uea.ac.uk
Abbreviations: CCK, cholecystokinin; CLA, conjugated linoleic acid; GLP-1, glucagon-like peptide-1; 1,25(OH)2D3, 1,25 dihydroxyvitamin D3; UCP2,
uncoupling protein-2.
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WHO projections suggest that by 2015, approximately
2·3 billion adults will be overweight and more than 700
million obese (Table 1). In the UK, it is projected that within
this time frame, 67·7 % of adults will be overweight(3).
Dairy consumption patterns worldwide
Per capita consumption of dairy products is generally
higher in the majority of developed countries relative
to less developed countries(4). The average per capita
consumption of dairy products in the European Union
(twenty-five countries) is 92·6 litres for milk, 18·4 kg for
cheese and 4·2 kg for butter per annum(5). Comparable
consumption patterns are evident in North America, with
annual per capita consumption of 94·7 and 83·9 litres of
milk, 12·2 and 16·0 kg of cheese and 3·3 and 2·1 kg of
butter in Canada and the USA, respectively(5). The most
recent estimates of dairy product consumption in the UK
from the Department for Environment, Food and Rural
Affairs’ Family Food Survey in 2008 indicate that total
milk consumption has decreased by 15 % whilst yoghurt
and cheese have increased by 34 and 10 % during the
last decade(6). Comparable changes in dairy consumption
patterns are evident throughout the European Union and
North America(7–9).
Although dairy products undoubtedly represent the
major source of dietary Ca, there is recognition that for
a subgroup of individuals dietary supplements make a
significant contribution to their total intake, although at
a population level the contribution is likely to be relatively
minor. For example, in a 2009 report detailing supplement
use in nine European countries dietary supplements were
reported to contribute 0·1–5·1 % and 1·3–8·5 % of total
intake in male and female adults, respectively(10). In reality
this may be an overestimation, with many individuals
purchasing supplements but consuming them on an
infrequent basis.
Scope of the review and an overview of the strengths and
limitations of available evidence
The association between dairy product/Ca consumption
and body weight regulation has been widely investigated
with data from epidemiological and intervention studies
in both adults and children summarised in numerous
recent reviews(11–22). In a number of studies reporting on
the association between dietary Ca and adiposity and its
regulation, no distinction is made between dairy and
non-dairy Ca sources, making it difficult to establish
whether the beneficial component is likely to be Ca or
an alternative milk bioactive component whose intake is
highly correlated with total Ca intake.
To our knowledge, no recent review has examined the
impact of dairy products on both body composition and
appetite, which represents the primary focus of the present
review. Relevant articles were abstracted through the
PubMed database, Google Scholar, and the cited references
of these reports using the following key words: ‘dairy’,
‘milk’, ‘BMI’, ‘weight’, ‘body composition’, ‘appetite’, ‘sati-
ety’ and ‘calcium’. These key words produced 4716 hits.
Articles available only in abstract form or not published
in English were excluded. Studies conducted in children
and adolescents were not included in the present review.
All observational or intervention studies which exclusively
examined the impact of Ca supplements were not
reviewed since the focus is dairy products and not Ca
per se. However, where a direct comparison between the
impact of dietary or dairy Ca and supplemental Ca is made
the data are included, as it provides a valuable insight into
the potential bioactive components in dairy products.
Using these criteria a total of 118 articles, which examined
the impact of milk, milk products, or dietary Ca (which is
mainly derived from dairy sources) on adiposity and its
regulation in adults, were considered. This number does
not include the mechanistic studies in cells or animals
that are mentioned in the mechanistic section of the
present review.
The initial evidence to indicate an association between
dairy consumption was derived from cross-sectional
studies. However, it is recognised that this type of study
design is receptive to inverse causation bias, meaning
that the presence of adiposity in individuals may affect
dairy consumption habits. Prospective studies represent
a more robust design. Unless otherwise stated in the text,
it is assumed that the associations between dairy and
adiposity cited in the text have been adjusted for the
main confounding factors such as age, sex, physical
activity, smoking status, alcohol consumption, fibre
intake and energy intake. The validity of the adjustment
of association models for total energy intake needs to
be carefully considered when interpreting study results
and conducting cross-study comparisons. Given the
high degree of correlation between total energy intake
and adiposity, adjustment for total energy intake appears
Table 1. Current and projected age-standardised estimates for over-
weight and obesity by country for both sexes, aged 15–100 years*
BMI. . . $25 to , 30 kg/m
2 $30 kg/m2
2005 2015 2005 2015
Country
Prevalence
(%)
Predicted
prevalence
(%)
Prevalence
(%)
Predicted
prevalence
(%)
Argentina 38·2 34·7 31·2 44·1
Australia 43·1 44·1 24·3 33·4
Brazil 37·0 39·3 13·5 24·1
Canada 37·6 37·5 23·5 27·8
China 27·2 40·8 1·7 7·6
Greece 42·4 41·5 26·1 30·6
South Africa 32·3 33·0 21·0 23·5
UK 40·9 40·6 22·9 27·1
USA 34·9 29·4 39·2 53·0
* Calculated from data based on WHO factsheets(3).
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appropriate(23). However, given that the beneficial impact
of dairy constituents may be through an impact on appetite
and food intake and therefore energy regulation, the
adjustment for total energy intake may be misleading due
to correction of the model for the mediator of the effect.
Yet, the majority of the cross-sectional and prospective
studies adjust their models for energy intake.
Intervention trials represent the most ‘robust’ source of
data and are the most appropriate to support a cause–
effect relationship.
In addition to reviewing the published literature, the
present review includes a novel meta-analysis of eighteen
epidemiological studies, in an attempt to summarise the
relationship between dietary Ca intake and BMI, after
correction for trial effects. Further details of the data anal-
ysis methods employed and the selection criteria for the
inclusion or exclusion of individual studies are given later.
Throughout the text ‘Ca’ or ‘total Ca’ refers to both
‘dietary Ca’ (Ca derived solely from the total diet) and Ca
consumed as supplements, whilst ‘dairy Ca’ refers to the
Ca derived solely from dairy product consumption.
Epidemiological evidence of the effects of dairy product
consumption on body composition
Evidence from cross-sectional studies
Several cross-sectional studies have indicated an inverse
relationship between dairy consumption and body
weight (Table 2). Mirmiran et al.(24) showed that the
number of dairy servings was inversely correlated with
BMI (r 20·38; P,0·05) (Fig. 1)(24). Similar results were
observed by Varenna et al.(25) in early postmenopausal
women. However, no association was observed in lean
young Japanese women with low mean habitual dairy con-
sumption (40 g dairy products/1000 kJ)(26), and a low mean
BMI (20·8 kg/m2), which is suggestive of a possible thre-
shold level for either body weight or dairy consumption
below which no associations are observed.
Two studies have also examined the relationship
between dairy product consumption and the prevalence
of central obesity. Azadbakht et al.(27) showed that dairy
consumption is inversely associated with the prevalence
of an enlarged waist circumference (defined as . 102 cm
in men and . 88 cm in women), with OR by quartile of
1, 0·89, 0·74 and 0·63 (P,0·001) (Fig. 1), with a more
recent study from the same group confirming the earlier
associations between dairy and central adiposity(28).
A limited number of studies have examined the impact
of ‘type’ of dairy product on the associations between
dairy consumption and body composition. However, some
inter-study inconsistencies in the findings are evident.
Two studies, which observed no overall association
between total dairy consumption and adiposity, reported
that low-fat dairy consumption was either positively
associated with BMI and waist circumference(29) or was
inversely associated with waist-to-hip ratio(30). In the
studies of Snijder et al.(29) and Beydoun et al.(31) cheese
was positively associated with the prevalence of obesity
and central obesity. In contrast, milk and yoghurt were
negatively related to adiposity in Beydoun’s analysis,
while in Snijder’s study there were no significant inverse
associations (Table 2). However, both authors do state
that due to the fact that obese individuals often consume
low-fat dairy products in an attempt to lose weight,
cause–effect relationships are often difficult to explore in
cross-sectional studies. Marques-Vidal et al.(32) observed a
modest but significant negative relationship between milk
intake and BMI in men (r 20·10; P,0·001) and women
(r 20·04; P,0·001), which is consistent with the findings
of Dicker et al.(33). In contrast, Lawlor et al.(34) reported
that 2·8 % of the 4024 women who reported never drinking
milk had a lower BMI than those who drank milk. How-
ever, this subgroup probably includes lactose-intolerant
women and it is not representative of any meaningful
group within the general population. Therefore, overall,
the cross-sectional data suggest that ‘lower’-fat dairy
products such as milk and yoghurt are associated with
lower adiposity, with cheese having the opposite effect.
As far as Ca is concerned, numerous studies have
showed inverse associations between dietary Ca, and the
prevalence of obesity(33,35–39), central adiposity(28), body
weight(40,41) and sagittal abdominal diameter(42). To date,
seven studies have evaluated the association of dietary
Ca with adiposity according to sex or ethnicity(43–49),
with stronger associations evident in females relative to
males and in white women compared with black
women(43,44,49). However, due to the numerous differences
in the diet and overall lifestyles between men and women
and ethnic groups, the results regarding the impact
of sex and race on Ca–adiposity associations remain
controversial.
Evidence from baseline data in prospective studies
examined in a cross-sectional manner
Baseline data of cohorts from several prospective studies
with CVD, hypertension or type 2 diabetes incidence as
primary outcomes were used to examine associations
between dairy consumption and body composition
(mainly BMI)(50–57). Often, as adiposity measures did not
represent a primary outcome, these analyses have not
controlled for important confounding factors including
energy intake. However, their distinct strength is the size
of the cohort, ranging in size from 2245 to 110 792 parti-
cipants. The results from studies that examined dairy
consumption, dietary Ca and total Ca are summarised sep-
arately below. Briefly, among seven studies that examined
dairy consumption(27,55,56,58–61), two studies(27,58) showed
a statistically significant negative association and one
study(61) showed a positive association between increased
dairy consumption and BMI as demonstrated in Fig. 2.
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Table 2. Cross-sectional studies of dairy consumption and measures of adiposity
Study Study details Results and conclusion Adjustments
Mirmiran et al. (2005)(24)* The Tehran Lipid and Glucose
Study, 223 men, 239 women
(aged . 16 years)
A significant inverse relationship between BMI and servings
of dairy consumption per d. OR for being overweight were 0·78
(95 % CI 0·43, 0·92) and 0·89 (95 % CI 0·53, 0·95) for men and
women, respectively, with equivalent OR for obesity of 0·73
(95 % CI 0·40, 0·83) and 0·69 (95 % CI 0·34, 0·80), respectively,
when comparing Q1 and Q4
Age, intake of total energy, carbohydrate, fat,
protein, dietary fibre and physical activity
Varenna et al. (2007)(25)* 1771 early-postmenopausal
Italian women
An inverse relationship between dairy intake and BMI (Q1,
BMI 24·1 (SD 3·4) kg/m2 v. Q4, 23·2 (SD 3·4) kg/m2; P¼0·001)
Age, age at menopause, smoking
Murakami et al. (2006)(26) 1905 Japanese women
(aged 18–20 years)
No significant relationship between BMI and dairy consumption Residential block size of residential area, smoking,
alcohol, physical activity, experience of dieting,
intentional dietary change, rate of eating,
protein, fat and dietary fibre intake
Azadbakht et al. (2005)(27)* 375 men and 470 Tehranian
women (aged 18–74 years)
A significant inverse relationship between dairy consumption
and WC (OR by quartile: 1, 0·89, 0·74, 0·63; P,0·001)
Age, total energy, percentage of energy from fat,
BMI, use of blood pressure and oestrogen
medication, smoking and physical activity
Azadbakht & Esmaillzadeh
(2008)(28)*
926 Tehranian women
(aged 40–60 years)
Dairy consumption was negatively associated with WHR
(r 20·2; P,0·05)
Age, physical activity, depression, smoking,
coffee consumption, menopausal status,
marriage, parity, age, medication use and BMI
Snijder et al. (2007)(29)* The Hoorn Study, 852 men
and 1044 Dutch women
(aged 50–75 years)
No significant association between dairy consumption and BMI
(b 0·06 (SEM 0·04); P¼0·17) and WC (b 0·07 (SEM 0·11);
P¼0·51). Cheese was positively related to BMI (b 0·15
(se 0·08); P¼0·04)
Age, sex, total energy intake, fibre, physical
activity, alcohol, smoking status, income,
educational level and antihypertensive
medication use
Brooks et al. (2006)(30)* The Bogalusa Heart Study,
505 men, 801 women
(aged 20–38 years)
No significant relationship between dairy consumption and BMI
or WHR. Significant negative relationship between low-fat dairy
consumption and abdominal obesity in white males (P¼0·008)
Energy intake, age, physical activity outside
of work
Beydoun et al. (2008)(31) 7652 women and 6966 US
men (aged . 18 years)
Each serving of cheese was associated with a higher prevalence
of obesity (OR 1·14; 95 % CI 1·08, 1·21) and central obesity
(OR 1·11; 95 % CI 1·05, 1·17) while each serving of yoghurt was
inversely related to obesity (OR 0·51; 95 % CI 0·36, 0·71) and
central obesity (OR 0·51; 95 % CI 0·37, 0·70)
Age, sex, ethnicity, socio-economic status
(education and poverty income ratio),
energy intake and physical activity
Marques-Vidal et al. (2006)(32)* The Portuguese Health Interview
Survey, 17 771 men, 19 742
women (aged $ 18 years)
A significantly inverse relationship between BMI and milk
consumption (men: r 20·11, P,0·001; women: r 20·06;
P,0·001), with the strongest relationships in men and
premenopausal women
Age, number of meals, smoking, educational
level, usual activity at work and leisure time
physical activity
Dicker et al. (2008)(33) The Israeli National Health and
Nutrition Survey, 1371 men,
1411 women (aged 25–64 years)
Daily milk consumption was higher in normal-weight subjects (103·4
(SD 147·5) g) compared with overweight (85·7 (SD 122·3) g)
and obese subjects (84·5 (SD 135·1) g) (P,0·01)
Not stated
Lawlor et al. (2005)(34)* The British Women’s Heart and
Health Study, 4024 women
(aged 60–79 years)
Milk drinkers had higher BMI compared with non-milk drinkers
(BMI 27·6 and 26·4 kg/m2, respectively; P¼0·03)
Age
Rosell et al. (2004)(42) 301 Swedish men
(aged 63 years)
An inverse relationship between dairy fat consumption and
SAD in under-reporters (r 20·36; P¼0·001) and not in
non-under-reporters (r 20·04; P¼0·59)
Not stated
Q, quartile; WC, waist circumference; WHR, waist-to-hip ratio; SAD, sagittal abdominal diameter.
* Studies used post hoc analysis.
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Among six studies that examined dietary Ca(51,57,62–65),
four showed a negative association with BMI, with the
difference between the highest and lowest dietary Ca con-
sumption being 20·3 kg/m2 (P,0·01)(62), 20·6 kg/m2(51),
20·8 kg/m2 (P,0·001)(57) and 21·3 kg/m2 (P,0·001)(65).
One study showed no difference(64) and one(63), which
observed no overall group effect, reported an effect of
sex with men having higher (þ0·2 kg/m2) and women
lower (20·3 kg/m2) BMI between quintile 5 v. quintile 1
of dietary Ca intakes without the level of significance
being reported. Finally, two studies(52,66) also showed
a negative association between total Ca intake and
BMI (with differences between quintile 5 v. quintile 1 of
21·0 kg/m2 in the Iowa Women’s Health study(51) and
20·2 kg/m2 (P,0·001) in the Health Professionals
Follow-up Study(66)).
Only two studies have examined associations between
milk consumption and BMI, with a significant negative
association found in the Caerphilly study (P,0·001)(54),
whilst no significant difference (P¼0·50) was observed in
a prospective study by Ness et al.(50).
In conclusion, there are inconsistent results from
the baseline data of prospective studies examined in a
cross-sectional manner regarding the relationship between
dairy product consumption and BMI. This inconsistency
might be due to the fact that the data analysis conducted
has often not controlled for energy intake, therefore mask-
ing the potential impact of dairy consumption on adiposity.
Evidence from prospective studies
A number of prospective studies have observed that regu-
lar dairy consumption is inversely associated with weight
gain and abdominal obesity (Table 3)(67–71). For instance,
results of The Coronary Artery Risk Development
In Adults (CARDIA) 10-year study(70) showed a 19·7 %
lower incidence of obesity between quintile 5 (intake
frequency $ 35 times/week) and quintile 1 (0 to , 10
times/week) of dairy intake (milk, cheese, sour cream,
cream and yoghurt) in adults with a BMI $ 25 kg/m2
at baseline.
Two studies have specifically evaluated the association
between changes in consumption of dairy products and
long-term weight gain (9–12 years)(72,73). Rosell et al.(73)
analysed a cohort of middle-aged perimenopausal
Dairy product intake (servings/d)
1·6 1·9 2·6 3·5
O
R
0·5
0·6
0·7
0·8
0·9
1·0
1·1
1·2
1·3
Fig. 1. Risk for being overweight, obese and having an enlarged waist
circumference in relation to the daily intake of dairy products. (X), Men OR
for being overweight(24); (W), women OR for being overweight(24); (P), men
OR for being obese(24); (L), women OR for being obese(24); (B), OR for
enlarged waist circumference.
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Fig. 2. The association between BMI and dairy consumption, with the data derived from cross-sectional analysis of available baseline data from large prospective
cohorts. (p), Azadbakht et al.(27): The Tehran Lipid and Glucose Study; 21·8 kg/m2 (P,0·01). ( ), Choi et al.(56): The Health Professionals Follow-up Study;
þ0·3 kg/m2. (n), Liu et al.(55): The Women’s Health Study; þ0·2 kg/m2. (o), Alonso et al.(58): The University of Navarra Follow-up Study; 20·3 kg/m2 (P¼0·01).
( ), Engberink et al.(59): The Monitoring Project on Risk Factors for Chronic Diseases; þ0·4 kg/m2. ( ), Engberink et al.(60): The Rotterdam Study; 20·1 kg/m2.
( ), Toledo et al.(61): The PREDIMED study; þ0·4 kg/m2 (P¼0·04).
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Table 3. Prospective studies of dairy consumption and body composition
Authors Details Results and conclusion Adjustments
Newby et al. (2003)(67,68)* The Baltimore Longitudinal Study of Aging;
219 women, 240 men (aged 30–80 years),
14-year follow-up
A dietary pattern rich in low-fat dairy products and
high-fibre foods was associated with a smaller
increase in BMI and waist circumference (P,0·05)
Age and sex
Drapeau et al. (2004)(69) The Que´bec Family Study; 136 women and
112 men ($18 years), 6-year follow-up
A dietary pattern rich in whole fruit, skimmed and
partly skimmed milk was associated with less
body-weight gain and adiposity (b 2 0·20
(SE 0·09); P¼0·06)
Age and baseline body-weight indicators
Pereira et al. (2002)(70) The CARDIA study; 3157 men
(aged 18–30 years), 10-year follow-up
There was a 19·7 % reduction in incidence of obesity
between quintile 5 and 1 of dairy consumption in
adults with BMI $ 25 kg/m2 at baseline (P,0·001)
Age, sex, race, energy intake, study centre and
baseline BMI
Rajpathak et al. (2006)(72)* The Health Professionals Follow-Up Study;
19 615 men (aged 40–75 years),
12-year follow-up
Dairy consumption is not related to lower long-term
weight gain in men
Age, baseline weight, smoking, alcohol intake,
physical activity, glycaemic load, and intakes
of energy, total fat, cereal fibre, whole grains,
fruit and vegetables, caffeine, trans-fat, and
low- and high-energy soft drinks
Rosell et al. (2006)(73)* 19 352 perimenopausal women
(aged 44–55 years), 9-year follow-up
Differences in subjects’ BMI and type of dairy product
influence the association between weight change
and dairy consumption
Age, baseline height and weight, education, parity,
intakes at baseline of energy, fat, carbohydrate,
protein, fibre and alcohol, the absolute change
in intakes of these nutrients during follow-up
(quartiles), and the studied categories of
change in intake of the other four dairy products
presented in the table
Vergnaud et al. (2008)(74)* The SU.VI.MAX Study; 1245 men and
1022 women (aged . 45 years),
6-year follow-up
Milk (P,0·05) and yoghurt (P,0·05) were inversely
associated with 6-year weight and WC changes
in OW only men. Milk (P¼0·08) was positively
associated with WC changes in OW women.
Age, intervention group, baseline value of the
outcome, educational level, smoking, physical
activity, alcohol, energy intakes and mean
adequacy ratio
Snijder et al. (2008)(75)* The Hoorn Study; 1124 subjects
(aged 50–75 years), 6·4 year change
in weight
Higher dairy consumption was not associated with
changed in body weight, fat distribution or other
components of the metabolic syndrome (P.0·05)
Age and sex, total energy intake, baseline value
of the outcome, alcohol intake, smoking and
physical activity
CARDIA, Coronary Artery Risk Development In Adults; SU.VI.MAX, SUpple´mentation en VItamines et Mine´raux AntioXydants; WC, waist circumference; OW, overweight.
* Studies used post hoc analysis.
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women and reported that the type of dairy product and
the subject’s BMI at baseline influenced the association
between dairy consumption and body weight and abdomi-
nal obesity. Women with a constant $ one serving/d of
cheese and whole/sour milk consumption had a lower
risk of gaining $ 1 kg/year over 9 years, compared with
those with an intake of , one serving per d (for cheese
OR 0·85 (95 % CI 0·73, 0·99) and for whole/sour milk
OR 0·70 (95 % CI 0·59, 0·84))(73). When the analysis was
conducted based on BMI status, only normal-weight
women with a constant $ one serving/d of cheese and
whole/sour milk consumption had lower risk of
gaining $ 1 kg/year over 9 years. Vergnaud et al.(74)
showed inverse relationships between milk and yoghurt
intake and body weight only in overweight men. Two
studies also showed that baseline dairy consumption was
not related to weight gain during 6·4 years and
12 years(72,75). However, after stratification by BMI, Snijder
et al.(75) showed that higher dairy consumption was signifi-
cantly associated with an increase in BMI, waist and weight
only in normal-weight subjects. Therefore, overall, three
prospective studies(70,74,75) showed that overweight and
obese subjects could benefit more regarding body-weight
regulation with dairy consumption.
Regarding dietary Ca, results of a 23-year prospective
study(76) indicated no association between dietary Ca
intake and BMI. As the authors stated, in this cohort this
may be due to the high average intake of dietary Ca in
the Dutch population, suggesting a threshold of Ca intake
of approximately 800 mg/d above which no further benefit
is observed. Other studies have suggested a threshold of
500–600 mg/d(20) and 600–700 mg/d(29,47,77). A number
of prospective studies(72,74,75) also failed to show an
inverse association between a wide range of dietary Ca
intakes and body composition, even when further analysis
is conducted in subjects that consumed below the
suggested threshold of 700 mg Ca/d. These data support
the hypothesis that the observed associations appear to
be specific to dairy sources and that dairy components
other than Ca may be responsible as highlighted in the
next section.
Meta-analysis using the epidemiological evidence
A mixed-model regression analysis was conducted using
mean data reported in the above epidemiological studies
in an attempt to summarise the relationship between diet-
ary Ca intake and BMI after correction for trial effects(78).
The advantage of this methodology compared with
simple regression models is that it corrects the relationship
between BMI and the fixed effect of dietary Ca intake for
random effects of individual trials. Generally, there are
differences in measurement methods, in experimental
units, in observations and in the accuracy of measurement
across the studies. Thus, adjusting the regression for the
trial effect reduces type II error and the bias in the esti-
mation of the intercept and slope(78).
Studies were selected based on the following criteria:
(a) prospective and cross-sectional studies which exam-
ined the association between dairy products or dietary Ca
and BMI; (b) included cohorts where data are presented
as quartiles or quintiles of either dairy products or dietary
Ca. Due to the different methods of presenting the results
and different definitions of the serving portions of dairy
products among the studies it was impossible to transform
all the available data into meaningful forms of accurate
estimation of dairy product consumption. Thus, despite
the fact that the focus of the review was dairy products
and not Ca, dietary Ca was the only accurate measurement
of dairy intake.
A total of twenty-five studies were identified, with
four(43,52,66,72) excluded on the basis of reporting intakes
of total Ca (both dietary and supplemental Ca in combi-
nation) and three(39,56,61) on the basis that data on dairy,
but not Ca intake, were published. Thus, in the final model
eighteen studies were included (Fig. 3). There were no
significant effects of sex or type of study (prospective or
cross-sectional) on the relationship between Ca intake
and BMI. The relationship between the ‘adjusted BMI’
and dietary Ca intake for the eighteen trials is presented
in Fig. 3 with an overall linear regression equation of:
Predicted BMI ¼ 26·0 þ ð20·00111 £mean Ca
intakeÞ kg=m2ðP ¼ 0·004Þ:
Based on this equation, at 400 mg Ca/d (low dietary Ca
intake), a BMI of 25·6 kg/m2 is predicted, while for
1200 mg/d a BMI of 24·7 kg/m2 is predicted. In other
words, an increase in Ca intake of 800 mg/d is associated
with a decrease in BMI of 1·1 kg/m2.
Similar results were obtained when in the above model
of the eighteen studies (Fig. 3) the four studies that exam-
ined both dietary and supplemental Ca in combination
were also included (data not shown). When only the
four studies(43,52,66,72) that used total Ca (both dietary and
supplemental Ca) were analysed, the relationship between
Ca and BMI was not significant (P¼0·65), which highlights
the influence of different Ca forms. There is no doubt that
dietary Ca intake is not equivalent to dairy consumption,
although both are closely related, and dairy products still
remain the major source of dietary Ca. However, other
components in dairy products could play a beneficial
role in body-weight regulation, as discussed later.
Evidence from intervention trials of the effects of dairy
product consumption on body composition
There have been relatively few randomised intervention
trials examining the effect of dairy products on body
weight and other measures of adiposity, and generally
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bone health or blood pressure, rather than adiposity, has
represented the primary outcome. Although the published
studies differ greatly in many aspects of study design
(length of intervention, type of dairy product introduced),
they all had a parallel rather than cross-over intervention
approach. The order that the trials are discussed in the
present review is based on energy intake, with the clinical
trials without and with energy restriction presented
separately.
Evidence from intervention trials without energy
restriction
Numerous studies have been conducted in adults without
energy restriction(79–88) and with body composition
being the primary endpoint of six studies(79,86–90). Only two
trials showed weight gain(79,80). Barr et al.(79) showed that
both women and men who were in the increased milk
group gained body weight (0·6 kg and 0·5 kg, respectively;
P,0·01). However, the increase in weight was less than
predicted (2·5 kg) from the 1046 kJ/d added energy of
milk consumption (600 ml). Only a 418 kJ/d increase
in total energy intake was observed, implying a partial
compensatory effect of milk on energy balance. Lau et al.(80)
also showed that women in the milk supplementation
group (50 g milk powder/d), compared with the control
group, gained body weight (0·52 v. 20·26 kg; P,0·01)
and fat mass (0·42 v. 20·14 kg; P,0·01).
Conversely, seven trials(81–86) showed no significant
difference in body weight with milk supplementation or
dairy treatment, four of which were specifically designed
to assess bone health(81–84) and one blood pressure(85).
Thus, although weight is a very robust outcome to
measure, the studies should be interpreted with caution
due to the possible lack of statistical power needed to
detect significant differences in body weight.
Two studies(86,90) that were primarily designed to exam-
ine the effect of dairy consumption on abdominal obesity
failed to detect differences among the treatments.
For example, Wennersberg et al.(90) conducted a 6-month
randomised parallel study in middle-aged overweight
subjects with low habitual dairy intake (# two servings/d)
and traits of the metabolic syndrome. There were no
differences in BMI, body weight, waist circumference,
sagittal abdominal diameter, body fat mass and proportion
of body fat between the high dairy group (three to five
servings/d) and the control group (# two servings/d).
However, a post hoc analysis based on baseline Ca intake,
which divided the participants into two groups, above or
below the suggested threshold level of 700 mg Ca,
showed that subjects in the high dairy group, who had
a baseline Ca intake less than 700 mg, had lower waist
circumference (P¼0·003) and sagittal abdominal diameter
(P¼0·034) compared with those in the control group at
the end of the study. These findings further support the
evidence from epidemiological studies suggesting the
possible threshold effect of dietary Ca above which no
29
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Fig. 3. Data derived from cross-sectional analysis of baseline data from eighteen large prospective cohorts showing the association between BMI and total dietary
Ca intake adjusted for trial effects excluding the trials that reported only milk consumption. ( ), Van der Vijver et al.(51), men; ( ), Van der Vijver et al.(51), women;
( ), Abbott et al.(57); ( ), Engberink et al.(59); ( ), Djousse et al.(212); ( ), Liu et al.(55); ( ), Umesawa et al.(63) men; ( ), Umesawa et al.(63) women; ( ), Alonso
et al.(58); ( ), Wang et al.(213); ( ), Mirmiran et al.(24) men; ( ), Mirmiran et al.(24) women; ( ), Murakami et al.(26); ( ), Snijder et al.(29); ( ), Liu et al.(65);
( ), Azadbakht et al.(27); ( ), Jacqmain et al.(47) men; ( ), Jacqmain et al.(47) women; ( ), Eilat-Adar et al.(45) Strong Heart Study; ( ), Eilat-Adar et al.(45) Third
National Health and Nutrition Examination Survey; ( ), Van Dam et al.(64); ( ), Engberink et al.(60); ( ), Umesawa et al.(62); ( ), linear (overall),
y ¼ 20·001x þ 26·01 (P¼0·004).
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additional benefit of increased dietary Ca intake with
respect to body weight is evident.
Zemel et al.(88) conducted two intervention trials in
African-American adults, with adiposity being the primary
endpoint. The first 26-week randomised parallel trial was
a weight-maintenance study and findings indicated that
high dairy (three servings/d) compared with low dairy
(,one serving/d) consumption decreased total body fat
(22·158 v. 0·169 kg; P,0·01) and trunk fat (21·026 v.
20·357 kg; P,0·01) despite the fact that there was no
significant change in body weight. Recently, Zemel
et al.(89) conducted a 9-month study, of which the first
3 months were the weight-loss phase and months 4 to 9
the weight-maintenance phase when the high- or low-dairy
intervention was introduced. During the weight main-
tenance, there were no differences in weight and body
composition between the high dairy diet group (. three
servings/d) and the low dairy group (,one serving/d).
However, the high dairy diet group consumed 1038 kJ/d
(P,0·05) more energy for the first half of maintenance
and 837 kJ/d (P,0·05) more for the second half of
maintenance relative to the low dairy group. Thus, there
was no treatment effect on weight and body composition
in spite of the higher energy intake in the high dairy
group, where the additional energy would have been
expected to contribute to weight gain.
One 12-month study(86) included an intervention with
Ca derived from both dairy and supplemental sources
and no differences on body fatness and weight were
observed. However, in a 6-month follow-up, Eagan
et al.(87) demonstrated that the mean Ca intake, mainly
from dairy products, during the period of 18 months
predicted a negative change in fat mass (P¼0·04) when
the model was adjusted for baseline BMI. According to
their regression model, a Ca dose of 1200 mg/d predicted
0·631 kg fat mass loss while a dose of 500 mg/d predicted
a fat mass gain of 1·26 kg over 18 months in normal-
weight young women.
Overall, data from the majority of the studies reviewed
predict that body weight does not change due to increased
consumption of dairy products. Thus, consumption of
the recommended amount of dairy products could be
incorporated into weight-maintenance diets without caus-
ing potential body weight loss. Although the inclusion of
dairy products may have resulted in some undefined
energy compensation, there was a trend for individuals
in the dairy group to have an overall higher energy
intake(89,90), which may override any potential beneficial
effect attributable to their bioactive components.
Evidence from intervention trials with energy restriction
Five studies have explored the relationship between dairy
product consumption and alterations in fat mass and body
weight in an overweight and obese population during
energy restriction(77,88,91–93), with body composition
being the primary endpoint of four studies(77,88,91,92).
In the second 24-week trial of Zemel et al.(88), twenty-
nine subjects on an energy-restricted regimen (2092 kJ/d
below requirement) were assigned to a low-dairy (,one
serving/d) or high-dairy (three servings/d) diet. The data
suggested that high-dairy diets promote greater weight
and fat loss (211 and 29 kg, respectively; P,0·01) relative
to low-dairy diets (29 and 24 kg, respectively; P,0·01),
and in particular promoted abdominal fat loss (2-fold
greater loss in the high dairy v. the low dairy group;
P,0·01). High dairy intake also seemed to protect against
the loss of lean body mass during energy restriction(88).
Similar results were obtained when a diet rich in fat-free
yoghurt (three 170 g servings/d) was provided to obese
subjects during 3 months of energy restriction (2092 kJ/d
deficit). There was an 81 % (P,0·001) greater reduction
in trunk fat loss on the yoghurt diet v. the control diet
(#one dairy serving/d, no yoghurt)(91).
In contrast, three studies showed no evidence that a diet
high in dairy products enhanced weight loss by overweight
and obese individuals during periods of energy restric-
tion(77,92,93). In a 12-month study with 2092 kJ energy
deficit per d, fifty-four obese subjects were assigned to
either a high-dairy diet (1400 mg Ca) or a low-dairy diet
(about 700 mg Ca)(92). Body weight and fat loss did not
statistically differ between the high-dairy diet and the low-
dairy diet (weight loss: 9·6 kg and 10·8 kg (P¼0·56) and fat
loss: 9·0 kg and 10·1 kg, respectively). Similarly, Thompson
et al.(77) failed to show a difference in body weight
loss among three energy-restricted diets with 2092 kJ
energy deficit per d. Participants lost 11·8 kg in the high-
dairy (four servings/d) diet, 10 kg in the moderate-dairy
(two servings/d) diet and 10·6 kg in the high-fibre diet.
Based on the review of these studies the apparent discre-
pancy may be attributed to the possible threshold effect of
600–800 mg of dietary Ca above which weight loss is
enhanced. A lack of effect of dairy products on weight
loss as part of an energy-restricted diet was also reported
by Bowen et al.(93), although bone turnover was the primary
endpoint.
As far as Ca is concerned, three studies showed an
inverse association between Ca intake and weight
gain(94–96) and two studies(97,98), which included an
exercise intervention, concluded that diets rich in Ca may
contribute to weight maintenance in either normal-weight
or obese populations.
In summary, although there are inconsistent results
among the studies regarding the promotion of weight loss
with high-dairy diets, it is worth noting that inclusion of
dairy products as part of an energy-restricted diet did not
adversely affect weight loss. Future work needs to be con-
ducted in order to compare effects of high dairy consump-
tion with moderate and low dairy consumption on weight
loss under energy restriction. Finally, further research is
needed on the effect of the recommended dairy consump-
tion on body composition during exercise interventions.
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Intervention trials: dairy products v. dietary
and supplemental calcium
Two studies with body composition as their primary out-
come have included energy-restricted intervention with
both dietary Ca and supplemental Ca at comparable
doses, thereby allowing a direct comparison(94,99). As indi-
cated in Fig. 4, Zemel et al.(94) reported more effective
weight and body fat loss in obese subjects who were
under energy restriction (2092 kJ/d below requirement)
and received Ca as dairy products compared with a Ca
supplement. Those findings were further supported in
a recent multi-centre 12-week clinical trial conducted
in 106 overweight and obese subjects under the same
energy restriction (2092 kJ/d below requirement)(99).
The data suggested that a high-dairy diet promotes greater
fat loss (24·43 kg; P,0·0025) relative to high and low
supplemental Ca (22·23 and 22·69 kg, respectively;
P,0·0025), in particular trunk fat loss (P,0·05) and
waist circumference (P,0·025). However, it is noticeable
that no differences were observed in weight loss in the
second study(99). The authors suggested the low adherence
of subjects at one centre and consequently the loss of
statistical power as an explanation for the discrepancy.
No differences in BMI and weight were also observed in
a 12-month maintenance study(100) in postmenopausal
women who were randomly assigned to a high-dairy
diet (1200 mg Ca plus 7·5mg vitamin D3 daily), a high-
supplemental Ca diet (1200 mg Ca) and a control diet
(usual diet). However, the high-dairy diet resulted in a
greater loss of leg fat (P¼0·025) and a lower increase in
the sum of skinfolds thickness (P¼0·042) compared with
the high supplemental Ca. The greater effect of dietary
Ca v. supplemental Ca was also observed by Ochner &
Lowe(95), who showed an inverse effect of dietary Ca
and no effect of supplemental Ca consumption on
weight regain 12 months after control of energy intake
for 6 months (P¼0·048 for FFQ and P¼0·025 for food
records).
Summary of the evidence based on epidemiological
and intervention studies
Although inconsistencies between studies certainly exist,
the overall assessment of the epidemiological evidence
is suggestive of a modest negative association between
dairy consumption and body weight. The overall linear
regression analysis, based on the eighteen trials that exam-
ined dietary Ca (with the majority of dietary Ca derived
from dairy products), indicates that an increase in Ca
intake from 400 to 1200 mg/d would be associated with a
decrease in BMI from 25·6 to 24·7 kg/m2. Evidence derived
from intervention studies without energy restriction does
not predict any effect of dairy products on either weight
loss or weight gain. During energy restriction, although
the results are still inconsistent, there are indications of
a possible beneficial effect of dairy products in weight-
loss treatments whilst maintaining lean tissue in an over-
weight population. There is a possible threshold effect
of 600–800 mg of dietary Ca above which fat loss is
augmented. A stronger effect of equivalent Ca intakes as
dairy v. the supplemental form is indicative that dairy
components other than Ca may in part mediate the
beneficial impact on body weight and composition.
Mechanism underlying the impact of dairy
constituents on body-weight regulation
The potential mechanisms underlying the impact of dairy
constituents on the regulation of energy metabolism,
body weight or body fat have not been clearly elucidated.
The most highly cited plausible mechanisms refer to
dietary Ca and its effects on intracellular Ca, and sub-
sequent impact on adipocyte lipid metabolism and fatty
acid absorption from the gastrointestinal tract(101). How-
ever, a number of dairy constituents such as protein, fat
and their metabolites have also been widely reported to
play a potential role in weight regulation (Fig. 5).
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Fig. 4. The impact of dietary Ca consumption on adiposity. The effect of
three different diets (low in supplemental Ca (Low-Ca; 430 (SE 94) mg Ca/d);
high in supplemental Ca (High-Ca; 1256 (SE 134) mg Ca/d); high in dairy
Ca through high dairy product consumption (High-Dairy; 1137 (SE 164) mg
Ca/d)) on (a) 6-month body weight loss (P,0·01) and (b) 6-month body fat
change (P,0·01) in obese individuals under an energy-restricted interven-
tion. Values are means, with their standard errors represented by vertical
bars (adapted from Zemel et al.(94)).
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Mechanisms underlying the impact of calcium
on body composition
Effects of calcium on adipocyte lipid metabolism. Zemel
et al.(36,102) were the first to explore the association
between low Ca intake and fat accumulation. The authors
suggested that intracellular Ca2þ promotes energy storage
due to the stimulation of de novo lipogenesis through the
regulation of fatty acid synthase and inhibition of lipolysis
through the activation of phosphodiesterase 3B(103). The
concentration of intracellular Ca2þ in human adipocytes
is increased by the stimulation of Ca-regulating hormones
such as parathyroid hormone and 1,25 dihydroxyvitamin
D3 (1,25(OH)2D3)
(104). Low dietary Ca intake increases
blood concentration of calcitropic hormones (parathyroid
hormone and 1,25(OH)2D3) and intracellular Ca influx,
thereby decreasing lipolysis and increasing lipogenesis,
leading to increased TAG storage.
In addition to these functions, decreased 1,25(OH)2D3
may increase the expression of uncoupling protein-2
(UCP2) via the nuclear vitamin D receptor in white adipose
tissue and hence may contribute to improved thermo-
genesis (Fig. 5)(105,106). However, there are animal(107)
and human(108,109) studies showing no alterations of
UCP2 and consequently no differences in diet-induced
thermogenesis. Thus, the role of UCP2 is still not
clear, and other unknown mechanisms may lead to this
thermogenic effect.
The regulation of both UCP2 and intracellular Ca2þ by
calcitriol hormone appears to modulate apoptotic cell
death via a dose-dependent mechanism(110,111). Further-
more, some additional mechanisms have been proposed
by Zemel & Sun(110) who suggested that decreased
1,25(OH)2D3 (which is associated with higher Ca intakes)
down-regulates 11b-hydroxysteroid dehydrogenase type I
expression and decreases the concentration of glucocorti-
coid which consequently decreases the size of the adipose
fat deposit(112) (Fig. 5). In addition, the potential impact
of 1,25(OH)2D3 on adiposity includes effects on adipocyte
differentiation and proliferation via the regulation of
reactive oxygen species and inflammatory cytokines
(Fig. 5)(113). Finally, a low level of calcitriol has been
shown to decrease the expression of pro-inflammatory
factors (TNF-a and IL-6) and increase the expression
of anti-inflammatory factors (IL-15 and adiponectin) in
visceral fat(114).
Although the adipocyte fat metabolism hypothesis has
gained support from both cell-culture and rodent studies
as detailed above, recent human studies failed to show
an effect of dairy Ca on adipocyte and whole-body lipid
metabolism(108,115,116). Bortolotti et al.(116) have highlighted
potential flaws of the above hypothesis, including an
observation of a relationship between obesity with low
vitamin D and 1,25(OH)2D3 concentrations
(117,118) and
highlight that de novo lipogenesis is likely to make a
minor contribution to fat accumulation in humans on a
typical mixed Western diet. Since there is currently a pau-
city of data from human trials, further research is required
to explore the effect of Ca on human adipocyte fat
metabolism.
↑ Dairy product
consumption
Gut
↑ Absorbed Ca
↑ Dairy protein
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↓ Circulating 1,25(OH)2D3
↓ Circulating PTH
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↓ Lipogenesis
↑ Fat oxidation
↑ Energy expenditure
↑ Thermogenesis ↑ Lipolysis↓ Appetite
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↓ ROS generation
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↓ 11β-HSD expression
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Fig. 5. Proposed mechanisms underlying the effect of dairy intake on body adiposity (adapted from Scholz-Ahrens & Schrezenmeir(214)). " , Increase; MCFA,
medium chain fatty acids; # , decrease; CLA, conjugated linoleic acid; PTH; parathyroid hormone; 1,25(OH)2D3, calcitriol; GLP-1, glucagon-like-peptide-1; CCK,
cholecystokinin; GIP, glucose-dependent insulinotropic polypeptide; ACE, angiotensin-converting enzyme; 11b-HSD, 11b-hydroxysteroid dehydrogenase type I;
ROS, reactive oxygen species; UCP2, uncoupling protein-2; [Ca2þ]i, intracellular Ca; FAS, fatty acid synthase.
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Evidence of calcium effects on fat oxidation. Melanson
et al.(119) were the first to examine any association between
Ca intake and whole-body fat oxidation. Their results
suggest a positive correlation between total acute Ca
intake and 24 h (r 0·38; P¼0·03) and sleeping fat oxidation
(r 0·36; P¼0·04). However, a limitation of this study is the
fact that no correction for differences in protein intake was
made, with protein previously shown to have an effect on
weight regulation and thermogenesis(120,121). Therefore,
conclusions cannot be drawn from this trial regarding the
independence of the impact of Ca intake on fat oxidation.
A subsequent study by the same group(122) showed that a
high dairy Ca intake increased 24 h whole-body fat
oxidation by 28 % (P¼0·02) under a regimen with a combi-
nation of energy restriction (2510 kJ/d below requirement)
and exercise, with the latter being the main stimulus of the
fat oxidation. Several additional studies have examined the
effect of Ca or dairy consumption on fat oxidation and
energy expenditure, but the results are controversial
(Table 4)(89,108,109,115,116,123–125). Furthermore, the mech-
anism by which dietary Ca may mediate fat oxidation
requires further investigation, although an increase in
UCP2 associated with increased Ca intake may be
involved(105).
Evidence of calcium effects on fatty acid absorption and
postprandial fat metabolism. As previously mentioned,
an alternative mechanism that has been suggested to
be responsible for the effect of Ca and dairy product
consumption on body adiposity is reduced fat absorption
from the gastrointestinal tract (Fig. 5). This mechanism is
attributed to the capability of Ca(101) to increase faecal
excretion of fat via the formation of insoluble fatty acid
soaps in the gut or by binding of bile acids, which weakens
the formation of micelles(124,126–128). It is generally
accepted that high-Ca diets increase fat excretion
(Table 5)(126–129). In a recent meta-analysis conducted by
Christensen et al.(130) which examined the impact of Ca
intervention, both as dairy and supplemental Ca, a 0·99
increase of standardised mean difference in faecal fat
excretion (95 % CI 0·63, 1·34; P,0·0001) was observed
which corresponds to about 2 g/d with a moderate
heterogeneity among the studies (I 2 ¼ 49·5 %). However,
when only dairy trials were analysed, there was no hetero-
geneity and results indicated that dairy Ca consumption
of 1241 mg increased faecal fat excretion by 5·2 g/d (95 %
CI 1·6, 8·8) compared with low dairy Ca consumers
(,700 mg/d). Based on the authors’ estimates, this fat
excretion would translate into 1·9 kg body fat or 2·2 kg
Table 4. Studies evaluating the effect of calcium on fat oxidation
Authors Details Results and conclusion
Zemel et al. (2008)(89) A 9-month randomised trial; 338 subjects (obese)
Diets: (a) LD (,one serving/d); (b) HD (. three servings/d)
During the weight-maintenance phase (3–9 months),
the HD group had a greater RMR (P,0·08) and
increase in fat oxidation (P,0·01)
Cummings et al. (2006)(109) A within-subject randomised trial; six men and two women
(overweight)
Diets: (a) LDCa (176 mg); (b) HNDCa (calcium citrate)
(575 mg); (c) HDCa (532 mg)
HDCa and HNDCa subjects increased postprandial
fat oxidation rate compared with LDCa subjects
(mean change in 6 h fat oxidation from the fasting
state was 3·3 (SEM 2·5), 2·9 (SEM 2·3) and 26·5
(SEM 2·2) g/6 h, respectively)
Boon et al. (2005)(115) A randomised cross-over trial; twelve men, 3 £ 1 week,
24 h fat oxidation
Diets: (a) HCa/HD (1259 mg/d); (b) HCa/LD (1259 mg/d);
(c) LCa/LD (349 mg/d)
Fat oxidation of 108 (SE 7) g/24 h for HCa/HD 105
(SE 9) g/24 h for HCa/LD and 100 (SE 6) g/24 h for
LCa/LD. No statistically significant difference.
No influence on expression of genes that are
closely related to fat metabolism and are regulated
by serum 1,25(OH)2D3
Bortolotti et al. (2008)(116) A randomised cross-over trial; seven women and three men,
2 £ 5 weeks, 7 h fat oxidation
Diets: (a) dairy Ca (800 mg/d) with maltodextrin;
(b) maltodextrin
Ca supplementation had no effect on plasma PTH
concentration, on resting energy expenditure (250·6
(SE 12·6) or 249·4 (SE 13·3) kJ/h) and on fat
oxidation (58·4 (SE 2·2) or 53·8 (SE 2·2) mg/min)
compared with the placebo diet
Gunther et al. (2005)(123) A parallel randomised trial; nineteen women, 1-year
intervention
Diets: (a) LCa, dietary (,800 mg/d); (b) HCa dietary
(1000–1400 mg/d)
There was increased whole-body fat oxidation and
decreased PTH concentration with a diet rich in
dietary Ca, mainly from dairy food (P,0·05)
Jacobsen et al. (2005)(124) A randomised cross-over trial; eight women and two men,
3 £ 1 week, 24 h fat oxidation
Diets: (a) LCa/NP (500 mg Ca, 15 E% protein); (b) HCa/NP
(1800 mg Ca, 15 E% protein); (c) HCa/HP (1800 mg Ca,
23 E% protein)
No effect of Ca consumption on fat oxidation, 24 h EE
but 2·5-fold increase in faecal fat excretion during
the HCa/NP, LCa/NP and HCa/HP diets (14·2, 6·0
and 5·9 g/d, respectively; P,0·05)
Teegarden et al. (2008)(125) A parallel randomised trial; twenty-four women, 12 weeks
Diets (all under 2092 kJ/d energy deficit): (a) placebo
(,800 mg Ca/d); (b) 900 mg CaCO3/d; (c) three
servings of dairy products per d to achieve 900 mg Ca/d
Only the Ca-supplemented group had increased
fat oxidation (1·5 (SD 0·6) g/h; P¼0·02) during the
12-week intervention. No effects on total energy
expenditure were observed by all groups
LD, low dairy; HD, high dairy; LDCa, low in dairy Ca; HNDCa, high in non-dairy Ca; HDCa, high in dairy Ca; HCa, high Ca; LCa, low Ca; 1,25(OH)2D3, 1,25 dihydroxyvitamin
D3; PTH, parathyroid hormone; NP, normal protein; HP, high protein; E%, percentage of energy; EE, energy expenditure.
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body-weight loss over a year. However, due to the small
number of studies and the small number of participants
on each study, a dose–response relationship could not
be established. The importance of faecal fat excretion
on body-weight regulation remains to be confirmed by
long-term studies with more robust designs.
Furthermore, Jacobsen et al.(124) and Boon et al.(108)
(Table 5) implied that the impact of Ca on fat absorption
may be protein dependent. The authors suggested that
Ca is bound by dietary protein, especially caseins, and
that Ca–protein complexation may reduce the amount
of Ca available for the formation of fatty acid soaps(124),
and therefore may in part negate the impact of Ca on fat
absorption.
Lorenzen et al.(131) recently investigated the effect of
high Ca consumption from dairy products or supplemental
Ca on postprandial fat metabolism. Four isoenergetic meals
were used containing high (172 mg/1000 kJ), medium
(84 mg/1000 kJ) or low (15 mg/1000 kJ) amounts of Ca
from dairy products and a calcium carbonate supplement
(183 mg/1000 kJ). According to their findings, high Ca
intake from dairy products decreased postprandial lipae-
mia compared with the low Ca intake (adjusted area
under the curve about 19 % lower) and compared with
the supplementary Ca (about 17 % lower). The differences
between dairy v. supplemental Ca could be explained
by the differences in the chemical form of Ca (calcium
phosphate in dairy products being more soluble than
the calcium carbonate in the supplement(132)), a difference
in pH and in other bioactive components in dairy
products, which may have had an impact on the postpran-
dial lipaemic response.
Mechanisms and evidence of conjugated linoleic acid
effects on body composition
As already mentioned, data suggest that Ca from dairy
products has greater effects on body-weight regulation
than supplemental Ca(94,133), which would lead to the
hypothesis that dairy foods can influence body adiposity
by Ca-independent mechanisms. Conjugated linoleic acid
(CLA) is a potential group of bioactive components
which may have an impact, with dairy products,
beef and lamb representing the almost exclusive dietary
sources(134). Although the impact of CLA on body
fat mass and topography has been repeatedly demon-
strated in rodent models, the results of human trials are
equivocal(135). A recent review by Plourde et al.(136) indi-
cated that the differences in results may arise from the
different experimental design, age, sex, energy intake
and CLA metabolism of the participants, and the dose and
chemical form of the CLA isomer administered. The predo-
minant isomer of CLA in natural foods is the cis-9,
trans-11-CLA ‘rumenic acid’ which accounts for more than
90 % of the total CLA intake. However, it is strongly
suggested that other isomers, such as trans-10, cis-12-CLA,Ta
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may influence body-weight and fat changes(137). Thus,
it is questionable whether physiological doses of CLA,
consumed as dairy products, can have any meaningful
impact on body-weight regulation in humans. Further-
more, potential underlying mechanisms are poorly
understood, with proposed mechanisms suggesting
that CLA can inhibit fatty acid synthase and stearoyl-CoA
desaturase-1(137), enhance fat oxidation and thermogen-
esis and reduce lipogenesis and preadipocyte differen-
tiation and proliferation(138).
Effects of medium-chain fatty acids on
body composition
Dairy products are a source of medium-chain TAG of
which 6 : 0 (capronic acid), 8 : 0 (caprylic acid) and 10 : 0
(capric acid) collectively constitute 4–12 % of all fatty
acids in bovine milk, with 12 : 0 (lauric acid) comprising
2–5 %(139). Animal trials have shown decreased lipogenesis
and TAG synthesis with increased medium-chain fatty
acid intake(140). Likewise, clinical trials in human subjects
have revealed that diets rich in medium-chain fatty acids
are associated with a reduction in body fat in human sub-
jects(139,141–144). Tsuji et al.(143) assigned volunteers to diets
providing 9213 kJ/d and 60 g total fat/d, 10 g of which were
either medium-chain TAG or long-chain TAG, for 12
weeks. A reduction in body weight (medium-chain TAG:
26·12 kg; long-chain TAG: 24·78 kg) and body fat
(medium-chain TAG: 24·57 kg; long-chain TAG: 23·61 kg)
was observed in both groups, with greater effects in the
medium-chain TAG group, and particularly among subjects
with BMI $ 23 kg/m2. These findings were in general
agreement with another study(144) that provided 5 g of
medium-chain TAG, which is lower than the typical level
of medium-chain TAG intake (15 g)(145), and highlight the
potential role of medium-chain TAG in the putative
impact of dairy products on body composition.
Medium-chain fatty acids are transported directly via
the portal vein to the liver, increase postprandial thermo-
genesis and are rapidly oxidised to ketones via b-oxidation
rather than incorporated into adipose tissue TAG(146).
In addition, medium-chain fatty acids may contribute to
a reduction in fat mass through down-regulation of adi-
pogenic genes and PPAR-g(139), an essential transcription
factor of adipogenesis whose activation is stimulated by
the binding of lipophilic ligands(147).
Effects of proteins on body composition
Dairy products contain a number of bioactive peptides that
may act synergistically or independently with Ca to regu-
late body adiposity(148). The milk proteins casein(149) and,
particularly, whey are rich sources of potentially bioactive
peptides (casokinins and lactokinins, respectively) that
have been shown to inhibit angiotensin-converting
enzyme, and consequently inhibiting the production of
the angiotensin II hormone(148). In addition to the role of
angiotensin II in the regulation of vascular smooth
muscle function, vascular tone and blood pressure, it has
been shown to up-regulate fatty acid synthase expression,
resulting in adipocyte lipogenesis (Fig. 5)(150).
Milk proteins have also been shown to stimulate insulin
secretion, and whey proteins proved to be more insulino-
tropic compared with caseins or other animal and plant
proteins(151). This insulin secretion may directly affect food
intake regulation by suppressing appetite and, as a conse-
quence, indirectly affect body weight. Furthermore, dairy
proteins contain a high proportion (about 21–26 %)(152)
of the three branched-chain amino acids leucine,
isoleucine and valine with their unique role in stimulating
protein synthesis and in sparing lean body mass during
weight-loss regimens(153).
Mechanism underlying the impact of dairy constituents
on appetite regulation
There is accumulating evidence to suggest that specific
dairy product components affect body weight through
their effects on food intake regulation and satiety(154).
Food intake regulation
The peripheral and central nervous systems are involved
in both short-term and long-term regulation of food
intake by mechanisms and pathways that are distinct, yet
act synergistically to either stimulate or suppress food
intake(155).
Long-term regulation of food intake. The arcuate
nucleus in the hypothalamic region is where the major inter-
actions of the appetite-regulator hormones occur(156). The
hypothalamus plays a critical role in the long-term regulation
of food intake and is activated in response to hormones that
enter or are produced in the central nervous system(155,157).
The adipocyte-derived leptin and pancreatic insulin are the
two major anorexigenic (appetite-suppressing) hormones
involved in the long-term regulation of appetite(158) and
resistance in the brain to their actions causes stimulation
of appetite(159,160).
Ghrelin is theonlyknownorexigenic (appetite-stimulating)
hormone, which is produced primarily in the stomach, and
it has recently been suggested to contribute not only to the
short-term but also to long-term regulation of food
intake(161). Leptin and insulin, as regulators of feed intake,
increase the secretion of anorexigenic neuropeptides and
decrease the secretion of orexigenic neuropeptides
(Table 6), while ghrelin has the opposite effects(155).
Short-term regulation of food intake. Satiation refers to
the physiological factors that promote meal termination
while satiety refers to the events that influence the time
interval between meals. Hence, satiation and satiety regu-
late meal size and frequency, respectively(162). Both are
included in the short-term regulation of food intake,
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which involves peptides primarily found in the enteric
nervous system and entero-endocrine cells of the
gastrointestinal tract(163). The gastrointestinal tract, which
includes the stomach, endocrine pancreas, proximal small
intestine, distal small intestine and colon(156), initiates a
variety of satiety signals that act mainly through the brain-
stem. The brainstem is the principal centre that receives
and transmits neural (by vagal afferents) and hormonal
(by gut peptides) signals from the gastrointestinal tract(157).
A number of gut peptide hormones that have effects on
appetite and food intake have been indentified to date,
including cholecystokinin (CCK), glucagon-like peptide-1
(GLP-1), peptide tyrosine tyrosine, oxyntomodulin(164),
bombesin and ghrelin (Table 6)(165). The secretion and
regulation of these gut hormones depend not only on
the macronutrient composition of the diet but also on
neuroendocrine factors(164). Additionally, dietary bioactive
peptides such as the opioid-like peptides (casomorphins
and caseinomacropeptide) are detectable in blood follow-
ing the digestion of casein and may also induce satiety.
The bioactive peptides can act as satiety hormones them-
selves or can stimulate the gut hormones(166). Insulin and
leptin, although major long-term regulators of food
intake, are also involved in short-term regulation by
increasing the actions of peripheral satiation signals such
as CCK(167,168).
In summary, appetite is influenced by a number of pep-
tides and hormones derived from the adipose tissue, gas-
trointestinal tract and pancreas, which, through their
actions on the hypothalamus, the brainstem and the ner-
vous system, regulate long- and short-term food intake
(Table 6).
Dairy components and appetite regulation
Effects of dairy proteins. Among the dairy components,
the proteins have the greatest putative role in appetite
control. The satiating attributes of dietary protein relative
to carbohydrate and fat are well recognised, and diets high
in protein content are more satiating than low-protein
diets(120,169). It has been proposed that the effect of protein
in short-term food regulation is associated with the increased
plasma concentrations of gut peptide hormones known to
reduce gastric emptying, gut motility and appetite(170). This
effect is related to the source of protein(171). The major pro-
tein groups present in bovine milk are whey proteins (for
example, b-lactoglobulin and a-lactalbumin) and caseins
(as1-casein, as2-casein,b-casein and k-casein) which consti-
tute approximately 20 and 80 %, respectively(172). Whey
proteins emerge as potential regulators of body weight
and have been shown to have more potent effects on
appetite and anorexic gut peptide concentrations than
caseins(173–175). In contrast, Bowen et al.(176) showed no
differences between casein and whey proteins or among
whey, soya protein and gluten on ad libitum food
intake(177). Nevertheless, ghrelin and insulin concentrations
were significantly decreased whilst CCK and GLP-1 was
increased after whey, soya and gluten consumption com-
pared with glucose. Additionally, a reduction in ad libitum
energy intake of approximately 10 % (P,0·05) was
measured 3 h after casein and whey protein consumption
compared with glucose consumption(176,177). However,
a recent study by the same group revealed no impact of
whey protein consumption on ad libitum intake 4 h
after consumption compared with fructose and glucose
beverages(178). Diepvens et al.(179) showed that, although
milk protein had greater stimulatory effects on the
proposed satiety hormones CCK and GLP-1, this was not
correlated with self-reported satiety, implying that satiety
biomarkers do not always guarantee the highest satiety.
The fact that there is no mathematical association between
anorexigenic hormone responses and satiety is further sup-
ported by Veldhorst et al.(169). These discrepancies among
the studies of food intake may be due to different method-
ologies, possible interactions among the different macro-
nutrients, and due to the different time periods for which
food intake was assessed. Moreover, none of the above
studies except Anderson et al.(174) used a no-energy con-
trol preload; thus the effect of the preload consumption
on food intake suppression was not assessed.
Although both whey and casein proteins induce satiety,
they lead to different effects on appetite regulation(171).
Based on their contribution to protein synthesis and
their effects on plasma amino acid concentrations, whey
proteins have been classified as fast proteins and
caseins have been classified as slow proteins(180). This
classification represents the greater effect of whey on sup-
pressing food intake at 90 min and casein at 150 min after
meal consumption(181). Both caseinomacropeptide and
Table 6. Major hormones and neuropeptides that regulate food intake
Name Origin
Effect on
food intake
Long-term
Leptin Adipose tissue #
Insulin Pancreas #
Pro-opiomelanocortin Hypothalamus #
a-Melanocyte-stimulating hormone Hypothalamus #
Corticotrophin-releasing hormone Hypothalamus #
Thyrotropin-releasing hormone Hypothalamus #
Ghrelin GI tract "
Neuropeptide Y Hypothalamus "
Agouti-related protein Hypothalamus "
Melanin-concentrating hormone Hypothalamus "
Orexins Hypothalamus "
Short-term
Cholecystokinin GI tract #
Glucagon-like peptide-1 GI tract #
Peptide tyrosine tyrosine GI tract #
Oxyntomodulin GI tract #
Bombesin Stomach #
Opioids Dietary BAP #
Leptin Adipose tissue #
Insulin Pancreas #
Ghrelin GI tract "
# , Suppression; GI, gastrointestinal; " , stimulation; BAP, bioactive peptides.
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casomorphins, released upon the digestion of caseins,
interact with opioid receptors and slow gastrointestinal
motility contributing to the longer transit time(154). More-
over, whey (a by-product of cheese production)(181)
rich in glycomacropeptide (GMP) has been found to
have a greater effect on pancreatic and gastrointestinal hor-
mone secretion than whey alone or whey without
GMP(169,182,183). Veldhosrt et al.(183) recently showed that
subjects who consumed a breakfast containing whey with-
out GMP had a higher energy intake at lunch compared
with subjects who ate a breakfast containing whey with
naturally present 21 % GMP (3208 kJ and 2877 kJ, respect-
ively; P,0·05).
Effects of dairy carbohydrates. Carbohydrate intake
also contributes to satiety and appetite regulation(184).
Short-term studies (#1 d) have demonstrated that low-
glycaemic index foods increase satiety and reduce energy
intake by affecting the blood glucose concentration
and therefore the insulin response (glucostatic theory),
and by stimulating gut peptides such as CCK, GLP-1 and
peptide tyrosine tyrosine (PYY)(185,186). However, the
association between postprandial glycaemic response and
satiety is still an issue of debate(187,188).
Lactose, which is the only carbohydrate found in
milk(189), is traditionally classed as a low-glycaemic index
carbohydrate (glycaemic index of lactose 46) and may
contribute to the satiating impact of milk and dairy pro-
ducts. Bowen et al.(176) compared the acute postprandial
effect of whey and casein proteins, lactose and glucose
on energy intake and appetite hormones (ghrelin, GLP-1,
CCK and insulin) in overweight men. The energy intake
was 10 % lower and acute appetite was also lower after
the lactose and protein preloads comparing with glucose
and this was consistent with differences in plasma ghrelin
concentration.
Effects of dairy fats. Although fat is the least satiating
macronutrient(190), it may be one of the milk and dairy
product components that contributes to satiety(191). Similar
to proteins and carbohydrates, the type and the structure
of fatty acids, their chain length(192), and their degree
of saturation are characteristics that have an impact on
appetite(193). A recent review revealed that fat increases
gastrointestinal transit time, stimulates the secretion of
many gastrointestinal hormones (CCK, GLP-1, peptide
tyrosine tyrosine) and suppresses appetite and energy
intake as a result of fat digestion into NEFA(194). Haug
et al.(195) suggested that full-fat milk and fermented milk
further delayed gastric emptying compared with semi-
skimmed milk in favour of glycaemic regulation. Similarly,
Schneeman et al.(196) showed that there were greater CCK
responses after the ingestion of a dairy relative to non-dairy
fat source or a high-fat meal (38 % of energy) compared
with a low-fat meal (20 %), although that was not related
to greater satiety. However, any inhibitory effect of dairy
fat consumption on appetite and consequently body-
weight regulation may be inconsequential when the
higher energy intake that whole milk products provide is
considered.
Effects of calcium. Whether Ca plays a role in the
regulation of food intake remains to be determined. The
idea of a Ca-specific appetite control was first proposed
by Tordoff(197) who suggested that low concentrations of
Ca in the diets may promote a desire to eat or choose
foods rich in Ca content. A number of studies conducted
in rodents support the hypothesis(198–200). Paradis &
Cabanac(199) showed in a 6-week intervention that the
Ca-deprived group of rats chose a high-CaCl2 drinking
solution whilst the control and Ca supplemental group of
rats chose a low-CaCl2 solution.
However, in human subjects, only two studies have
examined the effect of either dairy or supplementary
Ca on appetite or food choice(131,201). A recent energy-
restricted study indicated that Ca and vitamin D sup-
plementation enhanced fat loss in women who were low
Ca (#600 mg/d) consumers (P,0·01). The difference in
fat and body-weight loss was highly correlated with a
reduction in lipid intake at an ad libitum buffet-type
lunch, implying that Ca may influence macronutrient
preferences. The authors speculated that since fats and
Ca tend to occur together in many foods, Ca-deficient
individuals might inadvertently, but preferentially, choose
to consume high-fat foods, such as cheese, as a conse-
quence of this association between nutrients, in order to
obtain dietary Ca. In contrast, Lorenzen et al.(131) showed
no significant effect of high dairy and supplementary Ca
consumption on appetite sensation, on the secretion of
appetite-regulator hormones, and on the subsequent
energy intake of the ad libitum meal.
Currently there is a lack of a plausible mechanisms link-
ing Ca with appetite, and a lack of understanding whether
any suggested evidence of an association between Ca
deficiency and appetite is due to Ca or a lack of other
dietary components that co-exist in Ca-rich foods. Further
studies are warranted to show how and if Ca deficiency,
which is commonly observed during energy-restriction
diets, can increase hunger, impair compliance and influ-
ence weight-loss outcomes.
Evidence of dairy product effects on appetite regulation.
There are relatively few studies that have examined the
effect of milk or individual milk products as whole foods
on appetite and satiety (Table 7)(202–210). To our know-
ledge, the first study that showed the higher satiety
response of yoghurt and cheese compared with similar
and energy-matched foods (1000 kJ) was by Holt
et al.(211). Their results indicated that consumption of
foods rich in protein, fibre and water content could poten-
tially reduce energy intake and promote weight loss. In a
cross-over study(206), where fifty-eight subjects consumed
either low (,one serving/d) or high (. three serving/d)
dairy products for 7 d, no significant difference in subjec-
tive appetite ratings was evident, although there was an
increase in energy intake by 874 kJ (P,0·05) during the
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Table 7. Studies of dairy consumption and their effect on food intake and appetite
Study Details Results and conclusion
Soenen & Westerterp-Plantenga (2007)(202) A within-subjects design
Study A: fifteen women and fifteen men
Study B: twenty women and twenty men
Stimuli: 4 £ 800 ml drinks containing no energy or 1·5 MJ from
sucrose, HFCS or milk
No differences in satiety and energy balance were observed 50 min after
consumption of HFCS, sucrose or milk preloads; 170 % mm (AUC)
VAS changes
Almiron-Roig & Drewnowski (2003)(203) A within-subjects design; fourteen men and eighteen women
Stimuli: orange juice, low-fat milk (1 %), regular cola and sparkling
water
The inclusion of orange juice, regular cola and low-fat milk (1 %) with a
lunch showed no significant differences in hunger, satiety and energy
intake in a lunch 2 h after ingestion
Harper et al. (2007)(204) A randomised cross-over study; twenty-two men
Stimuli: 500 ml cola or chocolate milk (900 kJ) was ingested 30 min
before an ad libitum lunch
No difference on ad libitum energy intake (3145 (SD 1268) kJ and 3286
(SD 1346) kJ after chocolate milk and cola, respectively) but chocolate
milk resulted in a significantly greater satiety and fullness 30 min after
their consumption (P,0·001)
Tsuchiya et al. (2006)(205) A within-subjects design; sixteen men and sixteen women
Stimuli: a semi-solid peach yoghurt (378 g), the same yoghurt in a
drinkable homogenised form (378 g), a peach-flavoured dairy
beverage (400 ml) and a peach juice beverage (400 ml)
Higher satiety following the two yoghurts (no difference between them)
compared with the beverages and no differences among them were
observed in energy intake 90 min after their consumption
Hollis & Mattes (2007)(206) A randomised cross-over study; twenty-eight men and thirty women
Stimuli: one portion of dairy/d or three portions of dairy/d for 7 d
No differences on subjective appetite ratings, although energy intake was
increased by 874 kJ/d (P,0·05) during the high-dairy consumption
period
Ruijschop et al. (2008)(207) A randomised cross-over study; forty-three women
Stimuli: 150 ml, 1·0 MJ of a fermented dairy beverage, non-
fermented dairy beverage (placebo) and a non-fermented
dairy beverage with 0·6 % Ca(C2H5OO)2
Fermented dairy beverage resulted in higher fullness (F ¼ 4·21; P¼0·02),
less hunger (F ¼ 4·49; P¼0·02) and less desire to eat (F ¼ 5·34;
P¼0·006). No differences were observed in energy intake 25 min after
the dairy beverage consumption
Dove et al. (2009)(208) A randomised cross-over study; thirteen men and thirty-four women
Stimuli: a fixed breakfast with either 600 ml skimmed milk or 600 ml
fruit juice (1062 kJ) provided 4 h before an ad libitum lunch
The mean energy intake at lunch was 2432 (95 % CI 2160, 2704) and 2658
(95 % CI 2386, 2930) kJ after consumption of the skimmed milk and fruit
juice, respectively, with the mean difference being 8·5 % (P,0·05)
Potier et al. (2009)(209) A within-subjects design; twenty-seven women
Stimuli: a cheesy snack containing 22 g protein (casein) (836 kJ),
a cheesy snack (whey þ casein, 2:1) (836 kJ) ingested 60 min
before an ad libitum lunch
The energy compensation at lunch was 83·1 (SEM 9·4) and 67·0 (SEM 16·4)
% for whey þ casein and casein cheese, respectively, and 121·6
(SEM 36·5) and 142·1 (SEM 29·7) % for whey þ casein and casein
cheese, respectively, considering the daily energy intake
Sanggaard et al. (2004)(210) A randomised cross-over study; eight men
Stimuli: 1·4 litres of milk or 1·4 litres of fermented milk plus 15 g
lactose
The gastric emptying was slower after the fermented milk than milk
(P,0·001) probably due to higher viscosity although there were
no significant differences in appetite
HFCS, high-fructose corn syrup; AUC, area under curve; VAS, visual analogue scale.
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high-dairy consumption period. The intake of dairy protein
was between 2·3 and 14·3 g/d, while in relevant studies that
observed a satiating effect of proteins, the intake of protein
was between 45 and 50 g/d(173,174). Thus, a possible
threshold level of dairy protein intake was not reached
and in combination with the short intervention time and
small sample size may explain the results. Furthermore,
whether fermented dairy products have a stronger effect
on appetite and satiety than non-fermented dairy remains
to be clarified(207,210).
Although in the majority of the above studies no
subsequent difference in energy intake at the ad libitum
meal was observed, not all of the studies have been
primarily powered to detect differences in energy intake.
In contrast, two recent studies, with energy intake as
their primary outcome, identified differences in energy
intake (Table 7)(208,209). Dove et al.(208) showed that satiety
was increased and energy intake at the ad libitum lunch
decreased 4 h after the consumption of skimmed milk
compared with an isoenergetic fruit drink in overweight
men and women. Potier et al.(209) also concluded that
the regular consumption of a moderate-energy cheese
snack (836 kJ) would not result in weight gain due to the
compensation observed not only at the ad libitum lunch
but also on the whole-day energy intake.
Further, longer-term and adequately powered studies
are required to investigate if habitual dairy product con-
sumption has an effect on appetite regulation and, as a
consequence, subsequent energy intake.
Conclusions
The incidence of obesity is increasing dramatically
worldwide. Dairy products are an integral part of the
Western diet. There is accumulating epidemiological data
based on cross-sectional (five studies) and particularly
prospective studies (seven studies) that show a modest
but significant inverse association between dairy product
consumption and body-weight gain. Only one study has
reported weight gain with consumption of dairy products,
indicating that dairy foods can be consumed as a major
source of nutrients during weight maintenance. Evidence
from intervention studies not involving energy intake
restriction is inconsistent regarding body-weight change
(Table 8), although nine studies out of twelve showed no
effect of dairy consumption specifically on weight loss.
During energy restriction, the data are also still inconsist-
ent. The interpretation of the relevant evidence is compli-
cated by the ability of humans to regulate energy intake.
Future studies that examine the relationship between
dairy products and body composition should use dairy
consumption both with and without adjustment for
energy intake. There is currently a paucity of evidence
regarding the impact of the type of dairy product on
the association between dairy consumption and body
composition.
Considering Ca, numerous epidemiological studies and
especially intervention trials with energy restriction
strongly support that dietary Ca is negatively associated
with measures of adiposity, highlighting its potential
beneficial effects as a component of weight-loss treat-
ments in overweight and obese individuals, in particular
individuals with a low habitual Ca intake (,700 mg/d)
(Table 8). A greater effect of dairy Ca than the supple-
mental form is suggestive that dairy bioactive components
other than Ca may also be involved.
Numerous plausible mechanisms underlying the
beneficial effect of dairy products on body-weight regu-
lation have been proposed. Currently the greatest strength
of evidence is available for Ca as a principal bioactive
Table 8. Studies that examined the association between dairy product consumption and dietary calcium* and measures of body composition
References Main conclusions
Cross-sectional studies
24, 25, 27, 28, 32, 33*, 35*, 36*, 37*, 38*, 39*,
40*, 41*, 42*, 43*, 44*, 47*, 49*
Inverse association between dairy products and measures of body composition
26, 29, 30, 45*, 46* No association
34, 48* Positive association
Prospective studies examined in a cross-sectional manner
27, 50*, 51*, 52*, 54, 57*, 58, 59, 62*, 65* Inverse association between dairy products and measures of body composition
50, 53*, 56, 64* No association
55, 56, 60, 61 Positive association
Prospective studies
67, 68, 69, 70, 71, 73, 74 Inverse association between dairy products and measures of body composition
72, 75, 76* No association
Intervention trials
Without energy restriction
87, 89 Inverse association between dairy products and measures of body composition
81–86, 88, 90, 100 No association
79, 80 Positive association
With energy restriction
88, 91, 94, 95*, 96*, 97*, 98* Inverse association between dairy products and measures of body composition
77, 92, 93, 99 No association
* Studies that examined dietary Ca.
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component with a proposed effect on adipocyte lipid
metabolism, lipogenesis and lipolysis, fat oxidation and
fat absorption. Additionally, dairy constituents such as
lactose, protein (in particular whey proteins) and their
peptide derivatives may have an effect on body weight
through the regulation of food intake and appetite.
Although the impact of individual dairy constituents on
food intake and appetite has been investigated to some
degree, there is a paucity of evidence from well-designed
intervention studies that examine the impact of dairy
product consumption, as whole foods, or the effect of
individual products on appetite and overall energy intake.
In conclusion, epidemiological data support the notion
of a benefit of dairy product consumption for weight
maintenance. However, there is an urgent need for well-
designed, long-term randomised intervention studies,
with adequate replication and with body-weight changes
and measures of adiposity as their primary outcomes,
in order to verify the potential benefits of specific dairy
products on weight regulation and weight and fat loss
and provide an insight into the underlying physiological
mechanisms.
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